AstraZeneca (AZN)

• Market cap: $212B
• 1 day: 0.11%
• 5 days: 3.80%
• 1 month: -2.33%
• 3 months: 0.77%
• 6 months: -1.43%
• Year to date: 8.97%
• 1 year: -5.39%
• 5 years: 37.32%
• 10 years: 109.67%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Employees: 94,300

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

39% more call options, than puts

Call options by funds: $491M | Put options by funds: $354M

7% more first-time investments, than exits

New positions opened: 157 | Existing positions closed: 147

0.85% more ownership

Funds ownership: 32.25% [Q3] → 33.1% (+0.85%) [Q4]

1% less repeat investments, than reductions

Existing positions increased: 421 | Existing positions reduced: 424

1% less funds holding

Funds holding: 1,212 [Q3] → 1,196 (-16) [Q4]

13% less capital invested

Capital invested by funds: $39B [Q3] → $34.1B (-$4.9B) [Q4]

19% less funds holding in top 10

Funds holding in top 10: 16 [Q3] → 13 (-3) [Q4]